Aug. 27 at 9:41 PM
$NVVE With the latest 8-K filing, the deal with Omnia is officially finalized. If all milestones are met, the total will reach approximately 7.5 million shares—including remaining toxic warrants—and a European BESS portfolio for Nuvve of 700 MW. Given the revenue this asset will generate, this implies an equity value of between
$350 million and
$700 million—or
$47 to
$93 per share on a fully diluted basis. Ultimately, I am glad I didn't sell at
$25.